文章核心观点 - 医疗数据与分析技术服务提供商Health Catalyst将于2025年2月26日盘后发布2024年第四季度及全年运营结果，并于同日下午5点召开电话会议回顾结果 [1] 会议详情 - 美国参与者拨打800 - 343 - 5172，国际参与者拨打203 - 518 - 9856，输入会议ID “HCATQ424” 接入电话会议 [2] - 可在https://ir.healthcatalyst.com/ 进行直播音频网络广播，会议结束后不久可在同一链接按需收听回放，回放约保留90天 [2] 公司介绍 - Health Catalyst是医疗数据与分析技术服务领先提供商，超1000家全球组织依靠其产品推动数亿患者记录产生有意义结果 [3] - 其云技术生态系统Health Catalyst Ignite™ 借助高价值数据、标准化指标和注册库及深厚医疗领域专业知识，帮助组织将复杂信息转化为可操作见解 [3] - 公司有数十年使命和交付数十亿美元可衡量成果的良好记录，持续推动医疗改善与创新 [3] 联系方式 - 投资者关系联系人：副总裁Jack Knight，电话 +1 (855) 309 - 6800，邮箱ir@healthcatalyst.com [4] - 媒体联系人：营销与传播高级副总裁Amanda Flanders，邮箱media@healthcatalyst.com [4]

文章核心观点 - 2025年Rezolve Ai发展势头迅猛，众多知名品牌采用其AI技术，与微软和谷歌的合作将推动其进一步扩张，有望重新定义全球零售互动 [1][4][5] 公司业务情况 - Rezolve Ai是全球领先的AI零售和商业解决方案提供商，其技术为超1600万消费者和110万个地点提供支持，每月有超1620万移动设备使用其技术，在110万个地点检测用户超2650万次 [1][2] - 公司的Brain Commerce、Brain Checkout和先进地理定位解决方案被采用，消除摩擦、优化客户旅程、增强实时个性化，为商业创新树立新标准 [4] 合作品牌案例 - Dunkin'利用Rezolve Ai的移动SDK进行得来速检测，实现快速取货和个性化数字菜单体验 [6] - BJ's Wholesale Club集成地理定位路边取货和差异化应用内体验，实现无缝店内互动 [6] - Coles Supermarkets利用非接触式杂货取货解决方案优化便利性 [6] - Discount Tire利用AI驱动的地理定位实现自动预约签到，减少客户服务时间 [6] - Philz Coffee部署非接触式取货解决方案，简化客户体验 [6] - Phoenix Suns在NBA和WBNA赛季期间，增强对前往体育场球迷的基于位置的营销 [6] 公司战略与展望 - 公司与微软和谷歌建立战略合作伙伴关系，将推动其进一步扩张，使零售商和品牌能大规模利用AI [4] - 公司将在2025年及以后重新定义全球零售互动 [5] 公司简介 - Rezolve Ai是AI解决方案行业领导者，专注于增强客户参与度、运营效率和收入增长，其Brain Suite提供先进工具，利用人工智能优化流程、改善决策并实现无缝数字体验 [6]

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a virtual fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 12:40 pm ET. A live webcast of the fireside chat can be accessed by visiting the Events and Presentations section of the Company’s website ...

PARIS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) will host a conference call and webcast on Thursday, February 20, 2025, at 10:00 AM (Eastern Time) to announce its fourth quarter and full year 2024 results. The press release will be sent before market opening. The conference call will be hosted by Jean-Marc Germain, Chief Executive Officer, and Jack Guo, Senior Vice President and Chief Financial Officer. Details of the conference call, webcast and accompanying presentation will be availa ...

New solution is enabled by the company’s OneTru™ platform and aims to increase transparency for lendersCHICAGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Despite a strong employment picture, some consumers are still struggling financially due to elevated inflation and higher than normal interest rates. The lowest income households (those earning less than $50,000) face another challenge, with only 35% indicating they have sufficient access to credit and lending products.i In an effort to provide lenders with a clea ...

BOSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025 at 8:40 a.m. ET. The fireside chat will be webcasted and avai ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, registrational-intent, multicenter Phase 2b trial of ACR-368 in patients with endometrial cancer and other tumor types Clinical data presented at ESMO 2024 demonstrates statistically significant segregation of patient responders in biomarker-positive versus biomarker-negative subgroups based on prospective OncoSignature patient selection (p-value = 0.009) Drug-tailored, propriet ...

Fort Lauderdale, FL, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm” or “Company”) (NASDAQ: RIME) – an AI technology and consumer electronics holding company, announced today the date of effectiveness and the ratio of a forthcoming reverse stock split (the “Reverse Split”) of the Company’s Common Stock (the “Common Stock”). On January 13, 2025, the Company announced, on a Current Report on Form 8-K, the voting results from the annual meeting of stockholders (the “Meeting”) held tha ...

MILWAUKEE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN) today reported results for the second quarter ended December 27, 2024. Fiscal Second Quarter 2025 Highlights Sales increased 23.2% year-over-year to $89.9 million, organic sales* increased 10.1%Net income attributable to Twin Disc was $0.9 millionEBITDA* increased 13.5% year-over-year to $6.3 millionOperating cash flow of $4.3MHealthy six-month backlog of $124.0 million supported by strong ongoing order activity CEO Perspective “Thi ...

SINGAPORE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced its bronze sponsorship of the International Bunker Industry Association (IBIA) Annual Dinner 2025 to take place on February 24 at the Grosvenor House Hotel in Mayfair, London. The annual event, which brings together key stakeholders, industry leaders, and decision makers from across the maritime and marin ...